Ecalta is used to treat patients from one month of age with invasive candidiasis (a fungal infection caused by a yeast called Candida). ‘Invasive’ means that the fungus has spread into the bloodstream. Ecalta contains the active substance anidulafungin.
Therapeutic Indication
### Therapeutic indication Treatment of invasive candidiasis in adults and paediatric patients aged 1 month to < 18 years.
Therapeutic Area (MeSH)
ATC Code
J02AX06
ATC Item
anidulafungin
Pharmacotherapeutic Group
Antimycotics for systemic use
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| anidulafungin | N/A | 阿尼芬净 |
EMA Name
Ecalta
Medicine Name
Ecalta
Aliases
N/A
